Last $0.78 USD
Change Today +0.006 / 0.78%
Volume 768.0
NEPH On Other Exchanges
Symbol
Exchange
OTC BB
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

nephros inc (NEPH) Snapshot

Open
$0.77
Previous Close
$0.77
Day High
$0.78
Day Low
$0.77
52 Week High
06/2/14 - $1.29
52 Week Low
02/5/14 - $0.30
Market Cap
19.6M
Average Volume 10 Days
3.7K
EPS TTM
$-0.17
Shares Outstanding
25.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NEPHROS INC (NEPH)

Related News

No related news articles were found.

nephros inc (NEPH) Related Businessweek News

No Related Businessweek News Found

nephros inc (NEPH) Details

Nephros, Inc., a commercial stage medical device company, develops and sells high performance liquid purification filters in the United States and Europe. It offers ultrafilters for dialysis centers, which filters water or bicarbonate concentrate for use in hemodialysis devices; and clearance of toxins from blood using an alternative method to hemodialysis in patients with chronic renal failure. The company also provides ultrafilters for hospitals and other commercial facilities that filters water for drinking and washing; and individual water treatment devices to produce safe drinking water for soldiers in the military and outdoor recreation field. In addition, it has two products in various stages of development in the hemodiafiltration (HDF) modality to deliver therapy for end stage renal disease patients, which include OLpur MDHDF filter series for HDF therapy; and OLpur H2H, an add-on module designed to allow the common types of hemodialysis machines for use in HDF therapy. The company was founded in 1997 and is headquartered in River Edge, New Jersey.

7 Employees
Last Reported Date: 04/10/14
Founded in 1997

nephros inc (NEPH) Top Compensated Officers

Chief Executive Officer, President, Acting Ch...
Total Annual Compensation: $350.0K
Compensation as of Fiscal Year 2013.

nephros inc (NEPH) Key Developments

Nephros, Inc. Appoints Matthew S. Rosenberg to its Board of Directors

Nephros, Inc. has appointed Matthew S. Rosenberg to its board of directors.

Nephros, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2014

Nephros, Inc. reported earnings results for the second quarter ended June 30, 2014. For the quarter, the company net loss was $654,000, or $0.03 per share compared to a net loss of $671,000, or $0.05 per share for the quarter ended June 30, 2013. Total net revenues were approximately $441,000 compared to approximately $575,000 for the three months ended June 30, 2013. Total net revenues decreased approximately $134,000, or 23%, arising from a decrease of approximately $143,000 in water filter sales on dialysis and commercial water partially offset by an increase of approximately $9,000 in licensing revenue related to the Bellco license agreement.

Rothstein-Kass, P.A. Resigns as Independent Registered Public Accounting Firm of Nephros, Inc

On June 30, 2014, KPMG LLP acquired certain assets of Rothstein-Kass, P.A. (d/b/a Rothstein Kass & Company, P.C.) and certain of its affiliates (Rothstein Kass), the independent registered public accounting firm that had been engaged by Nephros, Inc. as the principal accountant to audit the Company's consolidated financial statements. As a result of this transaction, Rothstein Kass has resigned as the independent registered public accounting firm for the Company, effective June 30, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEPH:US $0.78 USD +0.006

NEPH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Baxter International Inc $72.54 USD -0.56
Fresenius Medical Care AG & Co KGaA €54.29 EUR -0.13
Nikkiso Co Ltd ¥1,248 JPY -8.00
View Industry Companies
 

Industry Analysis

NEPH

Industry Average

Valuation NEPH Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 12.5x
Price/Book 90.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 12.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEPHROS INC, please visit www.nephros.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.